Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Rpl39 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL39 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Rpl39 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL39 mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Rpl39 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rpl39 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RPL39 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RPL39 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RPL39 mRNA | CTD | PMID:11752688 | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of RPL39 mRNA | CTD | PMID:28522335 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of RPL39 mRNA | CTD | PMID:28973697 | acrylamide | increases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of RPL39 mRNA | CTD | PMID:32763439 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RPL39 mRNA | CTD | PMID:16483693 | Aroclor 1254 | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of RPL39 mRNA | CTD | PMID:23650126 | arsenite(3-) | multiple interactions | ISO | RPL39 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to RPL39 mRNA] and arsenite promotes the reaction [G3BP1 protein binds to RPL39 protein] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of RPL39 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | RPL39 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of RPL39 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RPL39 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of RPL39 exon | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of RPL39 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | RPL39 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of RPL39 gene | CTD | PMID:31601247 | bisphenol A | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | bisphenol A results in increased expression of RPL39 mRNA | CTD | PMID:33221593 and PMID:38074096 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RPL39 protein | CTD | PMID:32145629 | bisphenol A | decreases expression | ISO | RPL39 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RPL39 mRNA | CTD | PMID:29275510 | bisphenol A | affects expression | ISO | RPL39 (Homo sapiens) | 6480464 | bisphenol A affects the expression of RPL39 mRNA | CTD | PMID:30903817 | bisphenol F | multiple interactions | ISO | RPL39 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of RPL39 gene | CTD | PMID:31601247 | cadmium dichloride | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of RPL39 mRNA | CTD | PMID:24982889 | carbon nanotube | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of RPL39 mRNA | CTD | PMID:25554681 | chlordecone | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Chlordecone results in increased expression of RPL39 mRNA | CTD | PMID:33711761 | chloropicrin | decreases expression | ISO | RPL39 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of RPL39 mRNA | CTD | PMID:26352163 | chromium(6+) | affects expression | ISO | Rpl39 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of RPL39 mRNA | CTD | PMID:28472532 | cisplatin | increases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of RPL39 mRNA | CTD | PMID:27392435 | clobetasol | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Clobetasol results in increased expression of RPL39 mRNA | CTD | PMID:27462272 | copper(II) sulfate | increases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of RPL39 mRNA | CTD | PMID:20599845 | copper(II) sulfate | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Copper Sulfate results in increased expression of RPL39 mRNA | CTD | PMID:18579281 | copper(II) sulfate | decreases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of RPL39 mRNA | CTD | PMID:20599845 | cylindrospermopsin | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | cylindrospermopsin results in increased expression of RPL39 mRNA | CTD | PMID:20936652 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of RPL39 mRNA | CTD | PMID:17379624 | dicrotophos | decreases expression | ISO | RPL39 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of RPL39 mRNA | CTD | PMID:28302478 | elemental selenium | decreases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Selenium results in decreased expression of RPL39 mRNA | CTD | PMID:19244175 | epoxiconazole | affects expression | ISO | Rpl39 (Mus musculus) | 6480464 | epoxiconazole affects the expression of RPL39 mRNA | CTD | PMID:35436446 | ethanol | affects expression | ISO | Rpl39 (Mus musculus) | 6480464 | Ethanol affects the expression of RPL39 mRNA | CTD | PMID:30319688 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of RPL39 mRNA | CTD | PMID:30307764 | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of RPL39 mRNA | CTD | PMID:18035473 | folic acid | multiple interactions | ISO | Rpl39 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL39 mRNA | CTD | PMID:22206623 | folic acid | decreases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of RPL39 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | RPL39 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of RPL39 gene | CTD | PMID:31601247 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of RPL39 mRNA | CTD | PMID:17341692 | hydralazine | multiple interactions | ISO | RPL39 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL39 mRNA | CTD | PMID:17183730 | hydrogen peroxide | affects expression | ISO | RPL39 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of RPL39 mRNA | CTD | PMID:20044591 | methidathion | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | methidathion results in increased expression of RPL39 mRNA | CTD | PMID:34813904 | mifepristone | increases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Mifepristone results in increased expression of RPL39 mRNA | CTD | PMID:17584828 | ozone | multiple interactions | ISO | RPL39 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of RPL39 mRNA | CTD | PMID:35430440 | paracetamol | affects expression | ISO | Rpl39 (Mus musculus) | 6480464 | Acetaminophen affects the expression of RPL39 mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Rpl39 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL39 mRNA | CTD | PMID:36331819 | resveratrol | decreases expression | ISO | Rpl39 (Mus musculus) | 6480464 | resveratrol results in decreased expression of RPL39 protein | CTD | PMID:25505154 | selenium atom | decreases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Selenium results in decreased expression of RPL39 mRNA | CTD | PMID:19244175 | simvastatin | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Simvastatin results in increased expression of RPL39 mRNA | CTD | PMID:19262002 | sodium arsenite | decreases expression | ISO | Rpl39 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of RPL39 mRNA | CTD | PMID:36209798 | sunitinib | increases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of RPL39 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | ISO | RPL39 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of RPL39 mRNA | CTD | PMID:31758290 | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of RPL39 mRNA | CTD | PMID:15963342 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of RPL39 mRNA | CTD | PMID:33387578 | trichloroethene | decreases methylation | EXP | | 6480464 | Trichloroethylene results in decreased methylation of RPL39 gene | CTD | PMID:27618143 | tungsten | increases expression | ISO | Rpl39 (Mus musculus) | 6480464 | Tungsten results in increased expression of RPL39 mRNA | CTD | PMID:30912803 | valproic acid | multiple interactions | ISO | RPL39 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL39 mRNA | CTD | PMID:17183730 | valproic acid | increases methylation | ISO | RPL39 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of RPL39 gene | CTD | PMID:29154799 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of RPL39 promoter | CTD | PMID:22570695 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RPL39 mRNA | CTD | PMID:23034163 | |